Early research (Phase 1)Active Not RecruitingNCT03459170
What this trial is testing
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
Who this might be right for
Hematologic Malignancy
Bellicum Pharmaceuticals 15